PSMD4 and hepatocellular carcinoma: Our results showed that HCC patients with low MCB1 expression exhibited superior prognosis following postoperative adjuvant TACE treatment, while patients with high MCB1 levels had poor response (Figure4A; Figure S6A, Supporting Information).